Osaic Holdings
SRPT icon

Osaic Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Osaic Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$30 – 8155
2025
Q3 		$30 Hold
2
– – ﹤0.01% 7812
2025
Q2 		$105 Hold
2
– – ﹤0.01% 7560
2025
Q1 		$2.08K Hold
2
– – ﹤0.01% 6582
2024
Q4 		$10.4K Hold
2
– – ﹤0.01% 5788
2024
Q3 		$11.2K Hold
2
– – ﹤0.01% 5751
2024
Q2 		$17.8K Hold
2
– – ﹤0.01% 5419
2024
Q1 		$13.5K Buy
2
+1
+100% +$122 ﹤0.01% 5581
2023
Q4 		$4.82K Buy
+1
New +$96 ﹤0.01% 6193

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Osaic Holdings's SRPT Position: Q2 2026 in Review

Osaic Holdings increased its Sarepta Therapeutics (SRPT) stake by 27% in Q2 2026, buying an estimated $48.1K and bringing the position to 11,801 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Osaic Holdings first reported a position in SRPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.4M in Q1 2023. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Osaic Holdings held 11,801 shares of Sarepta Therapeutics worth $212K as of Q2 2026.
  • Osaic Holdings bought 2,542 Sarepta Therapeutics shares in Q2 2026, an estimated $48.1K.
  • Sarepta Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4388 holding.
  • Osaic Holdings first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Sarepta Therapeutics position peaked at $3.4M in Q1 2023.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.